Form 13F security
STOK · Stoke Therapeutics
Class COM
As filed on Form 13F — long US-listed positions only. No shorts, cash, bonds, or non-13F assets appear here.
Filed up to 45 days after quarter end; holdings may have changed since.
Tracked managers holding it
Share and principal positions
| Manager | Quarter | Value | % of portfolio | SH/PRN qty | Put/call |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | 2026-06-30 | $17M | <0.1% | SH 517,275 | — |
Total $17M across 1 of 69 managers.
Sums are across tracked reports, not unique economic ownership.
BAILLIE GIFFORD & CO — Combined report.
Filed rows (4) — as filed
The filer reports some securities in multiple rows; rows are shown as filed.
| Manager | Class | Put/call | Value | % of portfolio | SH/PRN qty | Source |
|---|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | COM | — | $8.1M | <0.1% | SH 248,578 | 0001088875-26-000057 |
| BAILLIE GIFFORD & CO | COM | — | $4.4M | <0.1% | SH 135,734 | 0001088875-26-000057 |
| BAILLIE GIFFORD & CO | COM | — | $2.5M | <0.1% | SH 76,237 | 0001088875-26-000057 |
| BAILLIE GIFFORD & CO | COM | — | $1.9M | <0.1% | SH 56,726 | 0001088875-26-000057 |